PMID: 9650930Jul 3, 1998Paper

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group

Journal of Clinical Microbiology
M A PfallerS A Messer

Abstract

An international program of surveillance of bloodstream infections (BSIs) in the United States, Canada, and South America between January and December 1997 detected 306 episodes of candidemia in 34 medical centers (22 in the United States, 6 in Canada, and 6 in South America). Eighty percent of the BSIs were nosocomial and 50% occurred in patients hospitalized in an intensive care unit. Overall, 53.3% of the BSIs were due to Candida albicans, 15.7% were due to C. parapsilosis, 15.0% were due to C. glabrata, 7.8% were due to C. tropicalis, 2.0% were due to C. krusei, 0.7% were due to C. guilliermondii, and 5.8% were due to Candida spp. However, the distribution of species varied markedly by country. In the United States, 43.8% of BSIs were due to non-C. albicans species. C. glabrata was the most common non-C. albicans species in the United States. The proportion of non-C. albicans BSIs was slightly higher in Canada (47.5%), where C. parapsilosis, not C. glabrata, was the most common non-C. albicans species. C. albicans accounted for 40.5% of all BSIs in South America, followed by C. parapsilosis (38.1%) and C. tropicalis (11.9%). Only one BSI due to C. glabrata was observed in South American hospitals. Among the different specie...Continue Reading

References

Jan 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R Wingard
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Pfaller
Dec 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A VossJ F Meis
Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Abi-SaidS Vartivarian
Feb 1, 1995·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Brita BruunJørgen Stenderup

❮ Previous
Next ❯

Citations

Nov 30, 2000·Current Infectious Disease Reports·C M Toscano, W R Jarvis
Apr 24, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H Alonso-ValleM C Fariñas
Sep 5, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mustafa BakirAysegul Yagci
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A JandourekJ A Vazquez
Sep 15, 2007·The Journal of Clinical Investigation·Attila GácserJoshua D Nosanchuk
Jun 22, 2002·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Istar DolapciHaluk Guriz
Apr 13, 2013·Memórias do Instituto Oswaldo Cruz·Constanza Giselle TavernaCristina Elena Canteros
Jun 26, 2002·The Veterinary Record·R S MuellerM Shipstone
Jul 12, 2008·Oral and Maxillofacial Surgery·Chima Oji, F Chukwuneke
Mar 12, 2004·Surgical Infections·Sandra M SwobodaPamela A Lipsetta
Oct 17, 2006·Expert Opinion on Investigational Drugs·George AperisEleftherios Mylonakis
May 29, 1999·Antimicrobial Agents and Chemotherapy·K A MarrT C White
Mar 18, 2000·Journal of Chemotherapy·T F Patterson
Jun 25, 2003·Current Opinion in Infectious Diseases·Thomas A Clark, Rana A Hajjeh
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W E TrickUNKNOWN National Nosocomial Infections Surveillance System Hospitals
Mar 29, 2001·Drugs·A Marchese, G C Schito
Dec 18, 2012·Journal of Clinical Microbiology·Stephen A Moser
Sep 2, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C LeónUNKNOWN EPCAN Study Group
Mar 31, 2012·Journal of Clinical Microbiology·Constanza Giselle TavernaMaría Eugenia Bosco-Borgeat
Feb 14, 2006·BMC Infectious Diseases·Matteo BassettiClaudio Viscoli
Apr 12, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Yoav Golan
Jan 30, 2008·Antimicrobial Agents and Chemotherapy·Junichi MitsuyamaHirokazu Narita
Sep 18, 2008·Medical Mycology·Vasilios PyrgosShmuel Shoham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Related Papers

© 2022 Meta ULC. All rights reserved